August 1, 2025

Cel-Sci Corporation (CVM): Investor Outlook Reveals Massive 2,834% Upside Potential

Cel-Sci Corporation (NASDAQ: CVM) is capturing the attention of savvy investors with a jaw-dropping potential upside of 2,834.28%. As a clinical-stage biotechnology firm, Cel-Sci is carving..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Navigating a Potential 129.59% Upside Amidst Challenges

Emergent BioSolutions Inc. (NYSE: EBS) presents a compelling yet complex case for investors seeking opportunities in the healthcare sector, specifically within the specialty and generic drug..

ATAI Life Sciences N.V. (ATAI) Stock Analysis: 175% Potential Upside Ignites Investor Interest

ATAI Life Sciences N.V. (NASDAQ: ATAI) is making waves in the biotechnology sector with its promising pipeline of mental health treatments and the potential for substantial..

Personalis, Inc. (PSNL) Stock Analysis: Unveiling a Potential 30% Upside in the Healthcare Sector

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the diagnostics and research industry within the healthcare sector, is drawing significant attention from investors, fueled by a..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Is a 67.6% Upside Potential Within Reach?

Keros Therapeutics, Inc. (NASDAQ: KROS) is drawing significant attention in the biotechnology sector, where it is making strides with innovative therapeutics targeting disorders related to the..

Tourmaline Bio, Inc. (TRML) Stock Analysis: A Potential 151% Upside in the Biotech Sector

For investors looking to explore opportunities in the healthcare sector, Tourmaline Bio, Inc. (NASDAQ: TRML) presents a compelling case with its significant 151.69% potential upside, as..

Surmodics, Inc. (SRDX) Stock Analysis: Healthcare Innovator with Volatility Amidst Challenges

Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector specializing in medical devices and in vitro diagnostics, presents an intriguing opportunity for investors willing..

Sage Therapeutics, Inc. (SAGE) Stock Analysis: Navigating a Challenging Landscape with 265.80% Revenue Growth

Sage Therapeutics, Inc. (NASDAQ: SAGE), a player in the biopharmaceutical sector, is currently capturing attention with its significant revenue growth figure of 265.80%. Specializing in brain..

Tyra Biosciences, Inc. (TYRA): Investor Outlook Reveals 175% Potential Upside Amid Strategic Precision Medicine Developments

Investors in Tyra Biosciences, Inc. (NASDAQ: TYRA) have much to consider as the company continues to make strides in the biotechnology sector. With a current market..

Capricor Therapeutics, Inc. (CAPR): Investor Outlook with a 151.83% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is gaining substantial attention in the healthcare sector. Focused on developing innovative cell and exosome-based therapeutics, Capricor’s..

Kura Oncology, Inc. (KURA) Investor Outlook: Analysts Predict a 328% Upside Potential

Kura Oncology, Inc. (NASDAQ: KURA) is making waves in the biotechnology sector with its promising pipeline of cancer therapies. Despite its current stock price of $6.05,..

Phibro Animal Health Corporation (PAHC): Investor Outlook on Growth and Valuation in the Healthcare Sector

Phibro Animal Health Corporation (NASDAQ: PAHC) is a noteworthy player in the healthcare sector, particularly within the niche of drug manufacturers specializing in both specialty and..

Claritev Corporation (CTEV) Stock Analysis: Is a 17.88% Upside on the Horizon for This Healthcare Innovator?

Claritev Corporation (CTEV) is a noteworthy player in the healthcare sector, specializing in health information services, with a focus on data analytics and technology-enabled cost management..

Neuropace, Inc. (NPCE) Stock Analysis: Unveiling a Potential 101% Upside

For investors eyeing opportunities in the healthcare sector, particularly in the realm of medical devices, Neuropace, Inc. (NASDAQ: NPCE) presents a compelling case. With a market..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring a 52.53% Potential Upside in Healthcare

Enhabit, Inc. (EHAB), a healthcare company specializing in home health and hospice services, presents a compelling opportunity for investors with its significant potential upside. As the..

CureVac N.V. (CVAC) Stock Analysis: Navigating the Volatile Biotech Sector with mRNA Innovation

CureVac N.V. (CVAC), a pioneering entity in the biotechnology sector, has captured the attention of investors with its innovative approach to messenger ribonucleic acid (mRNA) technologies...

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 34.49% Potential Upside in the Telehealth Revolution

LifeMD, Inc. (LFMD) is making waves in the healthcare sector with its innovative approach to connecting consumers directly to healthcare professionals through its telehealth platform. As..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with a 6.47% Potential Upside

Sonida Senior Living, Inc. (SNDA) is a notable player in the healthcare sector, specifically within the medical care facilities industry in the United States. With a..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a 129.88% Potential Upside in the Biotech Sector

Sana Biotechnology, Inc. (NASDAQ: SANA) is making waves in the biotechnology sector with its innovative approach to using engineered cells as medicines. Headquartered in Seattle, Washington,..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 54% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH) is a biopharmaceutical company making waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $558.01..

Search

Funds

August 1, 2025

Search

Funds

August 1, 2025

FTSE 100

Funds